期刊文献+

普罗布考对糖基化终末产物引发心脏微血管内皮功能紊乱的作用 被引量:1

Effect of probucol on advanced glycosylation end product-induced dysfunction in cardiac microvascular endothelial cells
下载PDF
导出
摘要 目的:观察普罗布考(probucol)对糖基化终末产物(AGEs)作用后的心脏微血管内皮细胞iNOS表达的影响。方法:原代培养心脏微血管内皮细胞,AGEs(100 mg/L)体外模拟高糖环境,在probucol(5μmol/L,10μmol/L,20μmol/L)作用后,检测ROS、NO和iNOS变化情况。结果:与AGEs组比较,probucol组中ROS蛋白表达降低,NO生成增加,而iNOS蛋白表达降低,且显示有浓度依赖性。结论:probucol可能通过对抗氧化应激的途径,缓解AGEs引发的心脏微血管内皮功能障碍。 To observe the effect of probucol on the iNOS expression induced by advanced glycosyla- tion end products (AGEs) in cardiac mierovascular endothelial cells. METHODS: Primary cardiac mi- crovascular endothelial cells were cultured in vitro. After treatment with AGEs ( 100 rag/L) and probucol (5 μmol/L, 10 p, mol/L, 20 μmol/L), NO, iNOS and ROS protein expressions in all groups were detected and compared between groups. RESULTS: Compared with AGEs group, NO and iNOS protein expression increased and ROS protein expression decreased in groups treated with probucol. CONCLUSION: Pro- bueol is able to partially recover AGE-induced dysfunction in cardiac microvascular endothelial cells.
出处 《心脏杂志》 CAS 2012年第3期324-327,共4页 Chinese Heart Journal
基金 黑龙江省青年科学基金项目资助(QC2010040) 黑龙江省2011年研究生创新科研资金项目资助(YJSCX2011-299HLJ) 牡丹江医学院科学技术研究项目资助(2010-16)
关键词 心脏微血管内皮细胞 糖基化终末产物 普罗布考 诱导型一氧化氮合酶 cardiac microvascular endothelial cells advanced glycosylation end products probucol iNOS
  • 相关文献

参考文献6

  • 1Brownlee M. Biochemistry and molecular cell biology of diabetic complications[J]. Nature, 2001, 414(6865) :813 - 820.
  • 2Hamilton SJ, Chew GT, Watts GF. Therapeutic regulation of endothelial, dysfunction in type 2 diabetes mellitus [ J ]. Invited review, 2007, 4(2) :89 - 102.
  • 3Jiang JL, Zhang XH, Li NS, et al. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyitrans- ferase I and dimethylarginine dimethylaminohydrolase activity [ J ]. Cardiovasc Drugs Ther, 2006, 20(4):281 -294.
  • 4Kirkby NS, Hadoke PW, Bagnall AJ, et al. The endothelin system as a therapedtic target in cardiovascular disease: great expectations or bleak house? [ J ]. Br J Pharmacol, 2008, 153 (6) : 1105 - 1119.
  • 5成永霞,刘贵波,郭素芬,杨向红.AGEs诱发体外大鼠心脏微血管内皮细胞iNOS表达[J].基础医学与临床,2010,30(5):515-519. 被引量:3
  • 6Guzik TJ, Mussa S, GastaldiD, et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD (P)H oxidase and endothelial nitrieoxide synthase[J]. Circulation, 2002, 105 (14) : 1658 - 1662.

二级参考文献12

  • 1Small DL, Buchan AM. Mechanisms of cerebral ischemia: intracellular cascades and therapeutic interventions [ J ]. Cardiothorac Vasc Anesth, 1996, 10( 1 ) : 139 - 142.
  • 2Yan SF, Ramasamy R, Naka Y. Glycation, Inflammation, and RAGE: A scaffold for the macrovascular complications of diabetes and beyond [ J ]. Circulation Res, 2003, 93 (12) :1159 -1169.
  • 3Factor SM, Okun EM, Minase T. Capillary microaneurysms in the human diabetic heart [ J ]. N Engl J Med, 1980, 302:384 - 388.
  • 4Factor SM, Bhan R, Minase T, et al. Hypertensive diabetic cardiomyopathy in the rat: an experimental model of human disease[J]. Am J Pathol, 1981, 102:219 -228.
  • 5Fein FS, Sonnenblick EH. Diabetic cardiomyopathy [ J ] Cardiovasc Drugs Ther, 1994, 8 : 65 -73.
  • 6Gargiulo P, Giusti C, Pietrobono D, et al. Tamburrano Diabetes mellitus and retinopathy [ J ]. Dig Liver Dis, 2004, 36 (Suppl. 1) : 101 - 105.
  • 7Cook S. Coronary artery disease, nitric oxideand oxidative stress: the " Yin-Yang" effect-a Chinese concept for a worldwide pandemic Cardiology [ J ]. Swiss Med Wldy, 2006, 136 : 103 - 113.
  • 8Galen MP, Allan MR. The complex role of iNOS in acutelyrejecting cardiac transplants [ J ]. Free Radic Biol Med, 2008, 8 : 1536 - 1552.
  • 9Hwa JL, Heon S J, Dae JK. Inhibitory effect of citral on NO production by suppression of iNOS expression and NF- κB activation in RAW264. 7 cells [ J ]. Arch Pharm Res, 2008, 31:342 - 349.
  • 10Wang Tiarman, Yah Ming, Li Tieyue, et al. The role of iNOS-derived NO in the antihypertrophic actions of B-type natriuretic peptide in neonatal rat cardiomyocytes[ J]. Mol Cell Biochem, 2007, 302( 1 - 2) : 169 - 177.

共引文献2

同被引文献12

  • 1Brownlee M.Biochemistry and molecular cell biology of diabetic complications[J].Nature,2001,414(6865):813-820.
  • 2Inoguchi T,Tsubouchi H,Etoh T,et al.A possible target of antioxidative therapy for diabetic vascular complications-vascular NAD(P) H oxidase[J].Curr Med Chem,2003,10(17):1759-1764.
  • 3Hamilton SJ,Chew GT,Watts GF.Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus[J].Vasc Dis Res,2007,4(2):89-102.
  • 4Kirkby NS,Hadoke PW,Bagnall AJ,et al.The endothelin system as a therapeutic target in cardiovascular disease:great expectations or bleak house[J].Br J Pharmacol,2008,153(6):1105-1119.
  • 5Cheng Y,Guo S,Liu G,et al.Transplantation of bone marrow-derived endothelial progenitor cells attenuates myocardial interstitial fibrosis and cardiac dysfunction in streptozotocin-induced diabetic rats[J].Int J Mol Med,2012,30(4):870-876.
  • 6Cheng Y,Liu G,Pan Q,et al.Elevated expression of liver X receptor alpha (LXRα) in myocardium of streptozotocin-induced diabetic rats[J].Inflammation,2011,34(6):698-706.
  • 7魏平,梁瑞凯,谭明红,匡剑韧,宁宁.2型糖尿病肾病大鼠肾脏MCP-1与氧化应激相关性研究[J].第三军医大学学报,2011,33(19):2021-2024. 被引量:10
  • 8成永霞,郭素芬,刘贵波,冯玉宽,颜彬,王洪伟,于建渤,曹永,李志强,金在顺,陈丽丽,杨向红.普罗布考对心脏微血管内皮细胞eNOS脱耦联与NADPH氧化应激途径的影响[J].医药导报,2012,31(8):975-979. 被引量:2
  • 9成永霞,刘贵波,郭素芬,颜彬,王洪伟,曹永,于建渤,李志强,冯玉宽,孙成,杨向红,陈丽丽.AGEs诱发大鼠心脏微血管内皮细胞eNOS脱偶联[J].国际心血管病杂志,2012,39(5):298-301. 被引量:3
  • 10黄海,宋成运,马建新,杜大勇,赖晓辉,李运田,罗玉君.糖尿病性心肌病变患者血糖强化治疗前后血管内皮功能变化的研究[J].中国临床保健杂志,2012,15(5):514-516. 被引量:3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部